Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
This aggressive growth investor is looking at the bright side when it's raining on Wall Street.
Intellia Therapeutics Delivers a Q4 Beat
Intellia Therapeutics reported better-than-expected results for the fourth quarter thanks to a boost in its collaboration revenue.
2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street
Biotech companies can skyrocket in a short period because of excellent clinical or regulatory progress. And if we take the word of Wall Street analysts, some of them will do precisely that in the next...
These biotech companies’ strategic advancements are setting them up for long-term success.